Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study

Background There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagn...

Full description

Bibliographic Details
Main Authors: Husam Abdel‐Qadir, Madison Gunn, Iliana C. Lega, Andrea Pang, Peter C. Austin, Sheldon M. Singh, Cynthia A. Jackevicius, Karen Tu, Paul Dorian, Douglas S. Lee, Dennis T. Ko
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023643
_version_ 1797859016706097152
author Husam Abdel‐Qadir
Madison Gunn
Iliana C. Lega
Andrea Pang
Peter C. Austin
Sheldon M. Singh
Cynthia A. Jackevicius
Karen Tu
Paul Dorian
Douglas S. Lee
Dennis T. Ko
author_facet Husam Abdel‐Qadir
Madison Gunn
Iliana C. Lega
Andrea Pang
Peter C. Austin
Sheldon M. Singh
Cynthia A. Jackevicius
Karen Tu
Paul Dorian
Douglas S. Lee
Dennis T. Ko
author_sort Husam Abdel‐Qadir
collection DOAJ
description Background There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagnosed AF. Methods and Results This was a population‐based cohort study using linked administrative data sets. We studied 37 209 individuals aged ≥66 years diagnosed with AF in Ontario between April 2009 and March 2019, who had diabetes diagnosed 1 to 16 years beforehand. The primary outcome was hospitalization for stroke at 1 year. Cause‐specific hazard regression was used to model the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke. Restricted cubic spline analyses showed increasing hazard ratios (HR) for stroke with longer diabetes duration that plateaued after 10 years and increasing HRs for stroke with HbA1c levels >7%. Relative to patients with <5 years diabetes duration, stroke rates were significantly higher for patients with ≥10 years duration (HR, 1.45; 95% CI, 1.16–1.82; P=0.001), while diabetes duration 5 to <10 years was not significantly different. Relative to glycated hemoglobin 6% to <7%, values ≥8% were associated with higher stroke rates (HR, 1.44; 95% CI, 1.12–1.84; P=0.004), while other HbA1c categories were not significantly different. Conclusions Longer diabetes duration and higher glycated hemoglobin were associated with significantly higher stroke rates in patients with AF and diabetes. Models for stroke risk prediction and preventive care in AF may be improved by considering patients’ diabetes characteristics.
first_indexed 2024-04-09T21:22:41Z
format Article
id doaj.art-6333c89d2e784214a94bfb8c8730560c
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-09T21:22:41Z
publishDate 2022-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-6333c89d2e784214a94bfb8c8730560c2023-03-28T04:20:07ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-02-0111410.1161/JAHA.121.023643Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort StudyHusam Abdel‐Qadir0Madison Gunn1Iliana C. Lega2Andrea Pang3Peter C. Austin4Sheldon M. Singh5Cynthia A. Jackevicius6Karen Tu7Paul Dorian8Douglas S. Lee9Dennis T. Ko10Women’s College Hospital Toronto CanadaSchulich School of Medicine Western University London ON CanadaWomen’s College Hospital Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaDepartment of Medicine University of Toronto CanadaUniversity Health Network Toronto CanadaUniversity Health Network Toronto CanadaDepartment of Medicine University of Toronto CanadaUniversity Health Network Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaBackground There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagnosed AF. Methods and Results This was a population‐based cohort study using linked administrative data sets. We studied 37 209 individuals aged ≥66 years diagnosed with AF in Ontario between April 2009 and March 2019, who had diabetes diagnosed 1 to 16 years beforehand. The primary outcome was hospitalization for stroke at 1 year. Cause‐specific hazard regression was used to model the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke. Restricted cubic spline analyses showed increasing hazard ratios (HR) for stroke with longer diabetes duration that plateaued after 10 years and increasing HRs for stroke with HbA1c levels >7%. Relative to patients with <5 years diabetes duration, stroke rates were significantly higher for patients with ≥10 years duration (HR, 1.45; 95% CI, 1.16–1.82; P=0.001), while diabetes duration 5 to <10 years was not significantly different. Relative to glycated hemoglobin 6% to <7%, values ≥8% were associated with higher stroke rates (HR, 1.44; 95% CI, 1.12–1.84; P=0.004), while other HbA1c categories were not significantly different. Conclusions Longer diabetes duration and higher glycated hemoglobin were associated with significantly higher stroke rates in patients with AF and diabetes. Models for stroke risk prediction and preventive care in AF may be improved by considering patients’ diabetes characteristics.https://www.ahajournals.org/doi/10.1161/JAHA.121.023643atrial fibrillationdiabetesdiabetes durationglycated hemoglobinstroke
spellingShingle Husam Abdel‐Qadir
Madison Gunn
Iliana C. Lega
Andrea Pang
Peter C. Austin
Sheldon M. Singh
Cynthia A. Jackevicius
Karen Tu
Paul Dorian
Douglas S. Lee
Dennis T. Ko
Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atrial fibrillation
diabetes
diabetes duration
glycated hemoglobin
stroke
title Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
title_full Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
title_fullStr Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
title_full_unstemmed Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
title_short Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
title_sort association of diabetes duration and glycemic control with stroke rate in patients with atrial fibrillation and diabetes a population based cohort study
topic atrial fibrillation
diabetes
diabetes duration
glycated hemoglobin
stroke
url https://www.ahajournals.org/doi/10.1161/JAHA.121.023643
work_keys_str_mv AT husamabdelqadir associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT madisongunn associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT ilianaclega associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT andreapang associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT petercaustin associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT sheldonmsingh associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT cynthiaajackevicius associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT karentu associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT pauldorian associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT douglasslee associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy
AT dennistko associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy